David Lally Alimera Sciences, Apellis, Annexon Biosciences, EyePoint Pharmaceuticals, Genentech, Iveric bio, Novartis, Code C (Consultant/Contractor), Alimera Sciences, Allergan, Apellis, Novartis, Stealth BioTherapeutics, Code R (Recipient), Apellis, Aldeyra Therapeutics, Annexon Biosciences, Chengdu Kanghong Pharmaceutical Group, Emmes/The MacTel Project, EyePoint Pharmaceuticals, Genentech, Iveric bio, Kodiak Sciences, Neurotech, Novartis, Opthea, Optos, Stealth BioTherapeutics, Code S (non-remunerative);
Anthony Abbruscato Stealth BioTherapeutics, Code E (Employment);
Sari Yordi None;
Hasan Cetin None;
Victoria Whitmore None;
Gagan Kalra None;
Yavuz Cakir None;
Conor McConville None;
Sunil Srivastava None;
Justis Ehlers Adverum, Aerpio, Alcon, Allergan, Genentech/Roche, Novartis, Oxurion, Regeneron, Stealth BioTherapeutics, Iveric bio, RegenxBIO, Allegro, Apellis, Zeiss, Code C (Consultant/Contractor), Adverum, Aerpio, Alcon, Allergan, Genentech/Roche, Novartis, Oxurion, Regeneron, Stealth BioTherapeutics, Iveric bio, Zeiss, Code F (Financial Support)